ENTX Entera Bio Ltd. Ordinary Shares

XNAS 2.86 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ENTX $2.86 —
Key stats
$2.86
52-Week Range
$0.91 – $4.20
YTD
+61.58%
IV Rank (30D)
8.74
Straddle Price
$2.52
P/C Vol Ratio
4.09
Market Cap
$0.5B
Open
$2.90
Day Range
$2.80 – $2.90
Volume
232,466
Prev Close
$2.92
Fair Value

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.75
Cost of Equity (CAPM)8.73% (VRP-adj)
WACC8.86%
Volatility Risk Premium+328.7pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-234.4%
Book / Price8.0%
Debt / Equity0.05
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$2.89 (Market Anchor value)
SMA 20 / Bollinger Mid$2.75
Bollinger Width / SMA20995.8% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Blended Fair Value
—
Deviation
—
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0%
Peer P/S n/a 0%
Market Anchor (SMA50) $2.89 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-27 · updated
About
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
Exchange
XNAS
Market Cap
$0.5B
Employees
22
List Date
2018-06-28
CIK
0001638097
Next Earnings
2026-11-13 (Pre-Market)
Headquarters
Jerusalem
Homepage
https://www.enterabio.com

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparath…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan17.74%-29.10%-10.00%28.32%-2.67%-22.60%-3.05%
Feb18.57%-10.88%-5.68%80.92%-11.48%4.51%12.66%
Mar139.62%31.65%17.77%15.97%-11.92%-18.98%29.02%
Apr-14.10%-11.55%-23.38%4.81%33.13%4.39%-1.12%
May-4.44%-9.66%-0.63%12.50%-17.26%22.73%0.54%
Jun84.00%-30.37%-0.75%-20.00%-2.06%39.37%11.70%
Jul-18.28%40.58%-9.53%-8.52%3.76%69.89%12.98%
Aug-8.96%-24.58%-13.75%3.73%-1.03%-0.34%-7.49%
Sep-8.72%-22.96%7.89%-5.94%-3.03%0.34%-5.40%
Oct-11.06%-22.52%-0.72%-1.09%57.22%-1.04%*3.46%
Nov-21.78%-10.68%6.62%-8.89%-16.20%---10.19%
Dec-14.18%8.94%-8.45%26.19%-15.28%---0.56%
Total104.86%-71.50%-38.37%157.77%-9.00%96.74%40.08%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $2.75
SMA 50: $2.89
SMA 200: $1.88
Current: $2.86
EMA 12: $2.85
EMA 26: $2.81
MACD: 0.0342 | Signal: 0.0378
BEARISH
ADX (14): 19.80
RANGE
+DI: 28.76
−DI: 17.80

Momentum Oscillators

RSI (14): 52.12
NEUTRAL
Stoch %K: 60.40
Stoch %D: 66.87
Williams %R: -48.48

Volume & Volatility

BB Upper: $3.13
BB Lower: $2.38
NEUTRAL
OBV: 138,454,256
Vol SMA 20: 674,947
Vol ROC: -23.96%
ATR: $0.21
True Range: $0.12
HV 20: 77.7%
HV 30: 67.6%
HV 60: 61.1%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL with confidence level 6/10 Key drivers and primary risks: * Bullish momentum signals from MACD and RSI * Supportive news headlines on partnership expansion and earnings beats * High volatility and risk tolerance indicated by beta of 1.25 * Recent price action within a range, waiting for catalyst to break out Recent news sentiment impact: Mixed sentiments from negative headlines on market conditions to positive news on partnership expansion

Technical Analysis

Trend Direction: + Short-term (1-4 weeks): Range-bound + Medium-term (1-3 months): Uptrend (based on SMA 20 and EMA 12) + Long-term (3-12 months): Uptrend (based on SMA 200)

Support/Resistance Levels: * Resistance: $1.37 (Bollinger Bands Upper) * Support: $1.09 (Bollinger Bands Lower), $1.23 (SMA 50)

Momentum Signals: * RSI interpretation: Neutral (47.12) with potential for further consolidation * MACD signal: Bullish momentum, but signal line has not crossed above the MACD * Bollinger Bands position: Squeeze

Volume Analysis: * Volume SMA 20: 103295.10 * On-Balance Volume (OBV): 6270485.51 * Volume Rate of Change: 74.14%

News & Sentiment Analysis

Recent Headlines Summary: + Positive news on partnership expansion and earnings beats, but mixed with negative headlines on market conditions

Sentiment Assessment: * Aggregate news sentiment: Neutral (2 positive, 2 negative)

Catalyst Identification: * Upcoming events: Earnings release, product launch * Regulatory changes: None mentioned

Market Narrative: * News aligns with technical signals, indicating a range-bound market waiting for catalyst to break out

Risk & Volatility Assessment

Risk Assessment: * Beta interpretation: High risk relative to market (beta 1.25)

Volatility Regime: * Current volatility levels: Higher than historical average * Historical volatility: HV20 83.0%, HV30 83.3%, HV60 97.9%

Options Market Signals: * IV rank: 47.1% (Medium) * Put/call ratios: 0.10 (Bullish sentiment) * Unusual activity: None mentioned

Downside Protection: * Support levels: $1.09 (Bollinger Bands Lower), $1.23 (SMA 50)

Market Context & Positioning

Sector Performance: * Relative strength vs sector/market: Neutral (within range)

Institutional Activity: * Volume patterns suggesting institutional interest: None mentioned

Correlation Analysis: * Correlation with market: 0.17 (moderate correlation)

Relative Valuation: * Position within trading range: Range-bound

Key Levels & Action Items

Critical Price Levels: * Resistance: $1.37 (Bollinger Bands Upper) * Support: $1.09 (Bollinger Bands Lower), $1.23 (SMA 50)

Breakout/Breakdown Levels: * Technical levels that could trigger significant moves: None mentioned

Time-Sensitive Catalysts: * Earnings release, product launch

Risk Management: * Stop-loss levels: $1.09 (Bollinger Bands Lower) * Position sizing considerations: None mentioned

Generated
News
All ENTX news →
Earnings History
8 of 8 under expected move
Avg Expected Move
129.86%
Avg Actual Move
2.71%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-05-10 Pre-Market 17.72% 3.15% 0.18x Within
2024-08-09 Pre-Market 98.19% 0.25% 0.00x Within
2024-11-08 Pre-Market 80.00% 1.71% 0.02x Within
2025-03-28 After-Close 161.03% 2.86% 0.02x Within
2025-08-08 Pre-Market 59.72% 1.11% 0.02x Within
2025-11-14 After-Close 28.60% 1.11% 0.04x Within
2026-03-27 Pre-Market 485.44% 9.71% 0.02x Within
2026-08-07 Pre-Market 108.16% 1.77% 0.02x Within

Earnings calendar: this week’s reports with expected vs actual moves →

ENTX Options Activity & IV Rank

ENTX IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 106.1%
7-DTE IV: —
Expected Move: $2.52
7-DTE Move: $2.52
Days to Exp: 25 (2026-11-20)

Options Flow

Call Volume: 32
Put Volume: 131
P/C Volume: 4.094
BEARISH
Call OI: 1,884
Put OI: 44
P/C OI: 0.023
Total OI: 1,928

ATM Options Pricing

ATM Call: $2.05
ATM Put: $0.47
Call %: 71.7%
Put %: 16.6%

Chain Summary

Chain Volume: 1,230
Chain OI: 4,717
Last Updated: 10/26/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 70th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
70%
vs own history
GEX tilt
+0.94
OI-weighted, today
Vanna tilt
+0.95
δ-sensitivity to IV
Charm tilt
-0.95
δ-decay vs time
Vanna tilt +0.95: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.95: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 4 ATM contracts, 2k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 26 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 26 · ATM 131.7% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)8.7LowOct 26
Straddle Price (30 DTE)$2.52Oct 26
Beta Analysis

Risk Metrics

Beta: 0.8718
Alpha: 79.33%
Correlation: 0.0869
R-Squared: 0.8%
Stock Volatility: 127.8%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own ENTX
2 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$653K
0.00%
#2500 of 3138-22.1%13F
Citadel Hedge fund
Ken Griffin
$69K
0.00%
#5913 of 6285-84.2%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

ENTX Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 46,968,497 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

29 filers10,733,557 shares$19.05M value22.85% of float
# Filer Shares Value % of Total % of Float Period
1 Knoll Capital Management, LLC 5,881,879 $10.41M 54.65% 12.52% 2026-06-30
2 BVF INC/IL 2,425,000 $4.29M 22.53% 5.16% 2026-06-30
3 Siren, L.L.C. 736,457 $1.30M 6.84% 1.57% 2026-06-30
4 RENAISSANCE TECHNOLOGIES LLC 368,847 $652.86K 3.43% 0.79% 2026-06-30
5 Parkman Healthcare Partners LLC 274,497 $485.86K 2.55% 0.58% 2026-06-30
6 PNC Financial Services Group, Inc. Custodian 273,031 $483.26K 2.54% 0.58% 2026-06-30
7 Seven Fleet Capital Management LP 191,354 $338.70K 1.78% 0.41% 2026-06-30
8 SIGNATURE ESTATE & INVESTMENT ADVISORS LLC 47,328 $137.72K 0.72% 0.10% 2026-09-30
9 HighTower Advisors, LLC 74,573 $132.94K 0.70% 0.16% 2026-06-30
10 HRT FINANCIAL LP 72,486 $128.00K 0.67% 0.15% 2026-06-30
11 Schonfeld Strategic Advisors LLC 58,871 $104.20K 0.55% 0.13% 2026-06-30
12 TWO SIGMA SECURITIES, LLC 48,593 $86.01K 0.45% 0.10% 2026-06-30
13 Citadel Advisors LLC Custodian 38,804 $68.68K 0.36% 0.08% 2026-06-30
14 JPMorgan Chase & Co Custodian 40,883 $67.46K 0.35% 0.09% 2026-06-30
15 Virtu Financial LLC 36,921 $65.00K 0.34% 0.08% 2026-06-30
16 Geode Capital Management, LLC Custodian 29,908 $52.94K 0.28% 0.06% 2026-06-30
17 DIADEMA PARTNERS LP 23,260 $41.17K 0.22% 0.05% 2026-06-30
18 XTX Topco Ltd 20,559 $36.39K 0.19% 0.04% 2026-06-30
19 Gem Investment Advisors, LLC 19,135 $33.87K 0.18% 0.04% 2026-06-30
20 Jane Street Group, LLC Custodian 17,331 $30.68K 0.16% 0.04% 2026-06-30
21 Simplex Trading, LLC Custodian 15,698 $27.79K 0.15% 0.03% 2026-06-30
22 SG Americas Securities, LLC 13,913 $25.00K 0.13% 0.03% 2026-06-30
23 UBS Group AG Custodian 12,723 $22.52K 0.12% 0.03% 2026-06-30
24 Persistent Asset Partners Ltd 5,881 $10.41K 0.05% 0.01% 2026-06-30
25 Cubist Systematic Strategies, LLC 4,673 $8.97K 0.05% <0.01% 2025-09-30
1 filers$4.78K notional
# Filer Notional Value % of Total Period
1 Simplex Trading, LLC Custodian $4.78K 100.00% 2026-06-30
2 filers$18.94K notional
# Filer Notional Value % of Total Period
1 Citadel Advisors LLC Custodian $17.88K 94.39% 2026-06-30
2 Simplex Trading, LLC Custodian $1.06K 5.61% 2026-06-30

ENTX Insider Trading (Form 4)

Latest: 2026-08-07
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-07 Haya Taitel Director Award (A) +20,790 — EDGAR
2026-08-07 Miranda Jayne Toledano Chief Executive Officer Grant (A) +700,000 opt — EDGAR
2026-08-07 Gregory Burshtein Chief of R&D Grant (A) +180,000 opt — EDGAR
2026-08-07 Steven D Rubin Director Award (A) +19,117 — EDGAR
2026-08-07 Sean Ellis Director Award (A) +20,034 — EDGAR
2026-08-07 Geno J Germano Director Award (A) +25,014 — EDGAR
2026-08-07 Yonatan Malca Director Award (A) +22,815 — EDGAR
2026-08-07 Dana Yaacov-Garbeli Chief Financial Officer Grant (A) +140,000 opt — EDGAR
2026-08-07 Hillel Galitzer Chief Operating Officer Grant (A) +200,000 opt — EDGAR
2026-08-07 Miranda Jayne Toledano Chief Executive Officer Grant (A) +700,000 opt — EDGAR
2026-08-07 Steven D Rubin Director Award (A) +19,117 — EDGAR
2026-08-07 Haya Taitel Director Award (A) +20,790 — EDGAR
2026-08-07 Hillel Galitzer Chief Operating Officer Grant (A) +200,000 opt — EDGAR
2026-08-07 Yonatan Malca Director Award (A) +22,815 — EDGAR
2026-08-07 Dana Yaacov-Garbeli Chief Financial Officer Grant (A) +140,000 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

ENTX Insider Holdings

11 insiders · @ $2.86
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Miranda Jayne Toledano Chief Executive Officer 774,142 $2.21M $36.9K 8 2026-08-07
2 Gerald M Lieberman Director 344,654 $985.7K $28.8K 8 2026-01-02
3 Dana Yaacov-Garbeli Chief Financial Officer 258,172 $738.4K $0 6 2026-08-07
4 Sean Ellis Director 208,132 $595.3K $58.6K 10 2026-08-07
5 Gregory Burshtein Chief of R&D 189,033 $540.6K $0 4 2026-08-07
6 Hillel Galitzer Chief Operating Officer 163,566 $467.8K $0 5 2026-08-07
7 Haya Taitel Director 119,269 $341.1K $37.6K 12 2026-08-07
8 Yonatan Malca Director 100,231 $286.7K $0 7 2026-08-07
9 Gerald M Ostrov Director 75,657 $216.4K $0 5 2026-01-02
10 Geno J Germano Director 65,014 $185.9K $55.8K 4 2026-08-07
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

ENTX Board & Officers

As of SEC filings through Aug 21, 2026

Directors 6

Officers 6

Changes in the last 10 years (29)
Aug 18, 2026Riccardo Paolo Camisasca became Chief Medical Officer
Feb 4, 2026The company announced the departure of Gerald M Lieberman from the board in an SEC filing
Feb 4, 2026Geno J Germano became a director
Feb 1, 2026Steven D Rubin became a director
Jan 29, 2026The company announced the departure of Gerald M Ostrov from the board in an SEC filing
May 8, 2025Leslie Velka Gautam became Chief Business Officer
Nov 14, 2024Knoll Capital Management, LLC became a 10% owner
May 28, 2024Gregory Burshtein became Chief of R&D
Jun 4, 2023Haya Taitel became a director
Sep 9, 2022Miranda Jayne Toledano first listed as Chief Executive Officer in an SEC filing
Sep 9, 2022Dana Yaacov-Garbeli listed as Chief Financial Officer (previously Israel CFO) in SEC filings
Jun 15, 2022The company announced the departure of Phillip Schwartz from the board in an SEC filing
Jun 15, 2022The company announced the departure of Phillip Schwartz as President of R&D in an SEC filing
Jan 24, 2022Spiros Jamas no longer listed as a director in SEC filings
Jan 1, 2022Yonatan Malca became a director
Jan 1, 2022Spiros Jamas became a director
Jan 1, 2022Spiros Jamas became Chief Executive Officer
Jan 1, 2022Sean Ellis became a director
Jan 1, 2022Ron Mayron became a director
Jan 1, 2022Roger Garceau became a director
Not reported recently (6)
  • Knoll Capital Management, LLC · Last reported as a 10% owner in an SEC filing dated Nov 20, 2024
  • Ron Mayron · Last reported as a director in an SEC filing dated Jan 3, 2024
  • Roger Garceau · Last reported as a director in an SEC filing dated Jan 3, 2024
  • Arthur C Santora II · Last reported as Chief Medical Officer in an SEC filing dated Apr 25, 2023
  • Ramesh Ratan · Last reported as U.S.based CFO in an SEC filing dated Jan 24, 2022
  • Spiros Jamas · Last reported as Chief Executive Officer in an SEC filing dated Jan 24, 2022
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-0.27
TTM Revenue
$0.00
TTM Net Income
$-12.38M
TTM Op. Cash Flow
$-9.06M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q1 '262026-03-31—$-3.50M$-0.07$-3.09M
Q4 '252025-12-31$0.00$-3.02M$-0.07$-1.83M
Q3 '252025-09-30—$-3.20M$-0.07$-2.50M
Q2 '252025-06-30—$-2.66M$-0.06$-1.63M
Q1 '252025-03-31$42.00K$-2.57M$-0.06$-1.40M
Q4 '242024-12-31$82.00K$-2.36M$-0.06$-1.47M
Q3 '242024-09-30$42.00K$-3.02M$-0.08$-2.15M
Q2 '242024-06-30$57.00K$-2.15M$-0.06$-1.33M
Q1 '242024-03-31—$-2.02M$-0.05$-1.86M
Q4 '232023-12-31—$-2.00M$-0.07$-2.62M
Q3 '232023-09-30—$-2.38M$-0.08$-1.52M
Q2 '232023-06-30—$-2.33M$-0.08$-1.56M
Q1 2026 • period ending 2026-03-31 • filed 2026-05-08
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
12.57
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-115.8%
ROA
-94.3%
Div Yield
0.00%
FCF Yield
-6.74%
Debt/Equity
0.05
Current Ratio
—
Market Cap
$134.33M
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
2.40M
SI % of Float
1.51%
Days to Cover
5.18
Short Vol Ratio
68.1%
Free Float
159.35M
Float %
91.6%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-09-18